LG-1041

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLG-1041
Drug Alias NameLG-1041
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionIduronate-2-sulfatase stimulants
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLentigen Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLentigen Technology Inc
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosis II

Other Information

ATC CodeN/A
Related LinksN/A